An evaluation of different enzymatic cleavage methods for recombinant fusion proteins, applied on des(1-3)insulin-like growth factor I
- PMID: 1388667
- DOI: 10.1007/BF01025226
An evaluation of different enzymatic cleavage methods for recombinant fusion proteins, applied on des(1-3)insulin-like growth factor I
Abstract
Different enzymatic methods for cleavage of recombinant fusion proteins were compared. To find an efficient cleavage method, five different fusion proteins were produced. The fusion proteins differed only in the linker region between the fusion partner and the desired product, human des(1-3)insulin-like growth factor I. A cleavage study was performed with enterokinase, plasmin, thrombin, urokinase, and recombinant H64A subtilisin. Significant cleavage was obtained using thrombin, H64A subtilisin, and enterokinase. Thrombin cleavage was studied on a larger scale and des(1-3)IGF-I was recovered at a final yield of 3 mg/L growth medium. Thrombin and enterokinase were also studied as immobilized proteases and they cleaved the fusion proteins with retained activity. To further improve thrombin cleavage, a continuous reactor was constructed, consisting of a closed system with a thrombin column and an ion exchange column in series. Here, the fusion protein circulated while free des(1-3)IGF-I was bound to the ion exchange column after release from the fusion protein. In the reactor, thrombin was as efficient as the free enzyme but gave a diminished rate of product degradation.
Similar articles
-
Thrombin and H64A subtilisin cleavage of fusion proteins for preparation of human recombinant parathyroid hormone.J Protein Chem. 1991 Oct;10(5):517-26. doi: 10.1007/BF01025480. J Protein Chem. 1991. PMID: 1799410
-
Separation and characterization of modified variants of recombinant human insulin-like growth factor I derived from a fusion protein secreted from Escherichia coli.Biochem J. 1990 Oct 15;271(2):357-63. doi: 10.1042/bj2710357. Biochem J. 1990. PMID: 2173560 Free PMC article.
-
Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.Biochem J. 1995 Nov 15;312 ( Pt 1)(Pt 1):49-55. doi: 10.1042/bj3120049. Biochem J. 1995. PMID: 7492334 Free PMC article.
-
A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa.Protein Expr Purif. 2003 Sep;31(1):1-11. doi: 10.1016/s1046-5928(03)00168-2. Protein Expr Purif. 2003. PMID: 12963335 Review.
-
Des(1-3)IGF-I: a truncated form of insulin-like growth factor-I.Int J Biochem Cell Biol. 1996 Oct;28(10):1085-7. doi: 10.1016/1357-2725(96)00056-8. Int J Biochem Cell Biol. 1996. PMID: 8930132 Review.
Cited by
-
Strategies for achieving high-level expression of genes in Escherichia coli.Microbiol Rev. 1996 Sep;60(3):512-38. doi: 10.1128/mr.60.3.512-538.1996. Microbiol Rev. 1996. PMID: 8840785 Free PMC article. Review.
-
Production of recombinant disulfide-rich venom peptides for structural and functional analysis via expression in the periplasm of E. coli.PLoS One. 2013 May 7;8(5):e63865. doi: 10.1371/journal.pone.0063865. Print 2013. PLoS One. 2013. PMID: 23667680 Free PMC article.
-
Substrate-assisted catalysis: molecular basis and biological significance.Protein Sci. 2000 Jan;9(1):1-9. doi: 10.1110/ps.9.1.1. Protein Sci. 2000. PMID: 10739241 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources